ImaginAb to Present at Upcoming Investor and Scientific Conferences in April and May 2019

LOS ANGELES, 17 April 2019 – ImaginAb Inc., a clinical stage immuno-oncology imaging company, today announces that it is scheduled to present at the following investor and scientific conferences in April and May 2019.

AIM at Melanoma

April 26-28, 2019, Hotel L’Echiquier Opera Paris, 38 Rue De L Echiquier, Paris

Dr. Anna Wu, Founder, and Board Director, and Ivan Plavec, CBO will be attending and making a presentation on ImaginAb at the 26th International Myeloma Working Group meeting in Paris.

Anglo-Nordic Life Science Conference

May 9, 2019, The County Hall, Belvedere Road, London

Ian Wilson, CEO, will be a panelist at the ‘Technologies and Treatments – What’s on the horizon’ discussion at 13.30 BST.

Bio€quity Europe 2019

May 20-21, 2019, Crowne Plaza Fira Center, Barcelona

Ian Wilson, CEO, and Ivan Plavec, CBO, will be attending and hosting meetings.

2019 ASCO Annual Meeting

May 31-June 4, 2019, McCormick Place, Chicago

Ian Wilson, CEO, Ivan Plavec, CBO, and Ron Korn CMO, will be attending and hosting meetings.



Ian Wilson


Phone: +1 310 645 1211

Optimum Strategic Communications

Mary Clark, Supriya Mathur


Phone: +44 20 3950 9144

About ImaginAb

ImaginAb Inc. is an immuno-oncology imaging company focused on providing actionable insight into patient selection and treatment progress for cancer immunotherapy, enabling precision medicine. ImaginAb engineers antibody fragments called minibodies that maintain the exquisite specificity of full-length antibodies while remaining inert in the body. Used with widely available PET scan technology, these novel minibodies illuminate high-value molecular targets, providing physicians with a whole-body picture of immune activity. ImaginAb is also developing a pipeline for other targets in oncology. ImaginAb’s products have the potential to improve patient care and lower healthcare costs.

For more information about ImaginAb’s pipeline and technology, visit